FDA Clearance Tracker · P100026-S021
NEUROPACE RNS SYSTEM
Last checked: Nov 20, 2026Latest source record: Sep 3, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Sep 3, 2014
Approved
Time to decision
76 days
Received Jun 19, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P100026-S021
- Device name
- NEUROPACE RNS SYSTEM
- Applicant
- NeuroPace, Inc.
- Applicant location
- Mountain View, CA
- Received
- Jun 19, 2014
- Decided
- Sep 3, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P100026
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for NeuroPace, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.